Ischemic cardiovascular disease: Correlation with Helicobacter pylori infection;Patologie cardiovascolari ischemiche: Correlazione con l'infezione da Helicobacter pylori

Minerva Cardioangiologica

Volumn 48, Issue 12, 2000, Pages 467-473

  Pellicano, R ^a,e   Oliaro, E ^b   Mangiardi, L ^b   Orzan, F ^b   Bergerone, S ^b   Gandolfo, N ^c   Aruta, E ^d   Rizzetto, M ^a   Ponzetto, A ^a  

^a Bone Marrow Transplant Unit   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d S GIOVANNI BOSCO HOSPITAL   (Italy)

^e Ainbulatori di Gastroenterologia   (Italy)

Author keywords

Cardiovascu lar diseases; Coronary heart disease; Helicobacter pylori; Myocardial infarction

Indexed keywords

CORONARY ARTERY DISEASE; HEART INFARCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; REVIEW; RISK FACTOR;

CORONARY DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0034569050     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world. Global Burden of Disease Study. Lancet 1997;349.1269-76.
2. Braunwald E. Shattuck letture- Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities. N Engl J Med 1997;337.1360-9.
3. Hennekens CH. Increasing burden of cardiovascular disease. Current knowledge and future directions for research on risk factors Circulation 1998,97:1095-102.
4. Jousilahti P, Vartialnen E, Tuomilehto J, Pekkanen J, Puska P. Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. Ann Med 1998;30.481-7
5. Cambou JP, Genès N, Vaur L, Renault M, Etienne S, Ferrières J et al Epidemiologie de l'infarctus du myocarde en France. Spécificités régionales. Arch Mal Cœur Vaiss 1997,90:1511-9.
6. Menotti A, Lanti M, Puddu PE, Kromhout D Coronary heart disease incidence in northern and southern european populations: a reanalysis of the seven countries study for a european coronary risk chart. Heart 2000; 84 238-44.
7. Lauria G, Gentile M, Fassctta G, Casetta I, Agnoli F, Andreotta G et al. Incidence and prognosis of stroke in the Belluno Province, Italy. Stroke 1995,20:1787-93.
8. Joseph LN, Babikian VL, Allen NC Risk factor modification in stroke prevention The experience of a stroke clinic Stroke 1999;30 16-20.
9. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A Blood-pressure control in the hypertensive population Lancet 1997;349 454-7
10. Bergman L, van der Meulen JHP, Limburg M, Habbema JD Costs of medical care after first-ever stroke in the Netherlands Stroke 1995;26:1830-6
11. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet 1999, 353(II):5-9.
12. Alpert JS The pathophysiology of acute myocardial infarction. Cardiology 1989;76 85-95.
13. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease - a possible trigger for acute myocardial infarction? Int J Epidemiol 1978;7:231-9
14. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease Lancet 1996;348.567-72.
15. Mattila KJ. Dental infections as a risk factor for acute myocardial infarction. Eur Heart J 1993;14:51-3.
16. Mattila KJ, Valtonen W, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998; 26:719-34.
17. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
18. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321.199-204.
19. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparent healthy men. N Engl J Med 1997;336:973-9
20. Ernst E, Hammerschmidt DE, Bagge TJ, Matrai A, Dormandy IA Leukocytes and the risk of ischemic diseases JAMA 1987;257:2318-24
21. Ponzetto A, Pellicano R, Mégraud F. Helicobacter pylori. Torino: Edizioni Minerva Medica, 1999.
22. Guidelines for clinical trials in Helicobacter pylori infection Working party of the European Helicobacter pylori study group. Gut 1997;41(suppl. 2):S1-S9.
23. Danesh J, Gasbarrini A, Cremonini F, Gasbarrini G, Helicobacter pylori infection and extradigestive diseases. Curr Opin Gastroenterol 2000;16 (suppl 1).S52-S55
24. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994, 71.437-9.
25. Pellicano R, Parravicini PP, Bigi R. La Rovere MT, Baduini G, Gandolfo N et al. Patients with acute myocardial infarction in Northern Italy are often infected by Helicobacter pylori Panminerva Medica 1999;41.279-82.
26. Folsom AR, Nieto J, Sorlie P, Chambless L, Graham DY. Helicobacter pylori seropositivity and coronary heart incidence. Circulation 1998;98:845-50
27. whincup PH, Mendall MA, Perry IJ, Strachan D, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996;75:568-72.
28. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JWG, Sweetnam PM et al. Relation of infection to 13-year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation 1998;98:1286-90.
29. Danesh J, Collins R, Peto R Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-6
30. Pellicano R, Mladenova I, Broutet N, Salmi LR, Mégraud F. Is there an association between Helicobacter pylori infection and coronary heart disease. Eur J Epidemiol 1999;15:611-9.
31. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
32. Danesh J, Youngman L, Clark S. Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999,319:1157-62.
33. Markus HS, Mendall MA. Helicobacter pylon infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurosurg Psychiatry 1998 64.104-7.
34. Pasceri V, Cammarota G, Patti G. Cuoco L, Gasbarrini A, Grillo RL et al. Association of virulent Helicobacter pylon strains with ischemic heart disease. Circulation 1998;97.1675-9.
35. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association ot cagA positive Helicobacter pylori strains with risk of premature myocardial infarction Heart 2000;84:267-71.
36. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P et al Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men Circulation 2000; 101:1647-52.
37. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes- ROXIS pilot study. Lancet 1997; 350:404-7.
38. Gupta S, Leatham EW, Canington D, Mendall MA, Kaski JC, Camm AJ Elevated Chlamydia pneumonias antibodies, cardiovascular events, and azithromycin in male survivor of myocardial infarction. Circulation 1997,96:404-7.
39. Kalian T, Lundman P, Olsson G, Wendt M. Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis 2000;11:523-6.
40. Pellicano R, Mazzarello MG, Morelloni S, Allegri M, Arena V, Ferrari M et al. Acute myocardial infarction and Helicobacter pylori seropositivity Int J Clin Lab Res 1999;29 141-4
41. Elizalde JI, Gomez, J, Panes J, Lozano M, Casadevall M, Ramirez J et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100.996-1005.
42. Blasi R, Denti F, Erba M, Cosenti R, Raccanelli R, Rinaldi A et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms J Clin Microbiol 1996;34:2766-9.
43. Gasbarrini A, Ponzetto A, Franceschi F, Pellicano R, Gasbarrini G. Helicobacter pylori infection and extra-digestive diseases. Curr Opin Gastroenterol 1998; 14(suppl.1):S65-S69.
44. Aguejouf O, Mayo K, Malfatti E, Doutremepuich C, Mégraud F. Artenal thrombosis and chronic Helicobacter pylori infection in mice. Gut 1998,43(suppl.2):A104
45. Kalia N, Bardhan KD, Reed MW, Jacob S, Brown NJ. Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo. Dig Dis Sci 2000,45:1343-51.
46. Choussat R, Montalescot G, Collet J, Jardel C, Ankri A, Fillet A et al. Effect of prior exposure to Chlamydia pneumoinae. Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol 2000, 86:379-84.
47. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G et al. Infection with Helicobacter pylori is not a major risk factor for stable coronary heart disease. Circulation 1999,100:2326-31.
48. Zito F, Di Castelnuovo A, D'Orazio A, Negrini R, De Lucia D, Donati MB et al. Helicobacter pylon infection and the risk of myocardial infarction: rôle of fibrinogen and its genetic control Thromb Haemost 1999;82:14-8
49. Torgano G, Cosentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G et al Treatment of Helicobacter pylon and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999;99 1555-9
50. Birnie DH, Holme ER, McKay IC, Hood S, McColl KEL, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Eur Heart J 1998,19:387-94.
51. Sung JJY, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease Heart 1996;76:305-7.
52. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2.